These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21671119)

  • 21. Domain organization of the ATP-sensitive potassium channel complex examined by fluorescence resonance energy transfer.
    Wang S; Makhina EN; Masia R; Hyrc KL; Formanack ML; Nichols CG
    J Biol Chem; 2013 Feb; 288(6):4378-88. PubMed ID: 23223337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four novel splice variants of sulfonylurea receptor 1.
    Hambrock A; Preisig-Müller R; Russ U; Piehl A; Hanley PJ; Ray J; Daut J; Quast U; Derst C
    Am J Physiol Cell Physiol; 2002 Aug; 283(2):C587-98. PubMed ID: 12107069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium.
    Lovasz N; Ducza E; Gaspar R; Falkay G
    Reproduction; 2011 Jul; 142(1):175-81. PubMed ID: 21527399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury.
    Lefer DJ; Nichols CG; Coetzee WA
    Trends Cardiovasc Med; 2009 Feb; 19(2):61-7. PubMed ID: 19577714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
    Hamming KS; Soliman D; Matemisz LC; Niazi O; Lang Y; Gloyn AL; Light PE
    Diabetes; 2009 Oct; 58(10):2419-24. PubMed ID: 19587354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.
    Russ U; Kühner P; Prager R; Stephan D; Bryan J; Quast U
    Br J Pharmacol; 2009 Jan; 156(2):354-61. PubMed ID: 19154434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two novel forms of the rat sulphonylurea receptor SUR1A2 and SUR1BDelta31.
    Gros L; Trapp S; Dabrowski M; Ashcroft FM; Bataille D; Blache P
    Br J Pharmacol; 2002 Sep; 137(1):98-106. PubMed ID: 12183335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
    Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
    Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.
    Zhou Q; Garin I; Castaño L; Argente J; Muñoz-Calvo MT; Perez de Nanclares G; Shyng SL
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E473-8. PubMed ID: 20810569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    Yan FF; Lin CW; Cartier EA; Shyng SL
    Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel.
    Lorenz E; Alekseev AE; Krapivinsky GB; Carrasco AJ; Clapham DE; Terzic A
    Mol Cell Biol; 1998 Mar; 18(3):1652-9. PubMed ID: 9488482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
    Proks P; de Wet H; Ashcroft FM
    J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).
    Babenko AP; Vaxillaire M
    FEBS Lett; 2011 Nov; 585(22):3555-9. PubMed ID: 22020219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
    Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
    Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
    Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP activates ATP-sensitive potassium channels composed of mutant sulfonylurea receptor 1 and Kir6.2 with diminished PIP2 sensitivity.
    Pratt EB; Shyng SL
    Channels (Austin); 2011; 5(4):314-9. PubMed ID: 21654216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
    Nielsen LB; Ploug KB; Swift P; Ørskov C; Jansen-Olesen I; Chiarelli F; Holst JJ; Hougaard P; Pörksen S; Holl R; de Beaufort C; Gammeltoft S; Rorsman P; Mortensen HB; Hansen L;
    Eur J Endocrinol; 2007 Jun; 156(6):663-71. PubMed ID: 17535866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
    Chen M; Dong Y; Simard JM
    J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.